deferasirox and Allergic Bronchopulmonary Mycosis
deferasirox has been researched along with Allergic Bronchopulmonary Mycosis in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Albert, ND; Kontoyiannis, DP; Lewis, RE | 1 |
Edwards, JE; French, SW; Gebremariam, T; Ibrahim, AS; Spellberg, B | 1 |
Other Studies
2 other study(ies) available for deferasirox and Allergic Bronchopulmonary Mycosis
Article | Year |
---|---|
Comparative pharmacodynamics of posaconazole in neutropenic murine models of invasive pulmonary aspergillosis and mucormycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus fumigatus; Benzoates; Caspofungin; Deferasirox; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Female; Invasive Pulmonary Aspergillosis; Lipopeptides; Lung; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mucormycosis; Neutropenia; Rhizopus; Treatment Outcome; Triazoles | 2014 |
The iron chelator deferasirox enhances liposomal amphotericin B efficacy in treating murine invasive pulmonary aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Benzoates; Deferasirox; Drug Synergism; Drug Therapy, Combination; Humans; Invasive Pulmonary Aspergillosis; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microbial Viability; Survival Analysis; Treatment Outcome; Triazoles | 2010 |